Pfizer’s recent settlement with DOJ to resolve FCA kickback claims alleging coordination with a charitable patient assistance program is the most recent example of increasing government scrutiny of PAPs. Justin Linder discusses this growing enforcement trend with Bloomberg Law reporter Matt Phifer in a July 30, 2018 article.
Read the full article: Charity for Gain: DOJ Eyes Patient Assistance Program Fraud
In a July 17th Order, the U.S. Court of Appeals for the District of Columbia dealt the latest blow to hospital groups’ challenge to the January 1, 2018 Medicare reimbursement reduction for drugs purchased under the 340B discount drug program, affirming the district court’s dismissal of the case on presentment grounds. Justin Linder discussed the implications of this development in a July 17th article published by Bloomberg Law.
Read the full article: Hospitals Lose Challenge to Rate Cuts for Safety-Net Drugs